Reported Oct 8, 2014 · Terminated
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by:…
AbbVie Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: AbbVie Inc · 1 N Waukegan Rd · North Chicago, IL · 60064
Is this the product you have?
- CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only
- Marketed byAbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07
- Lot codes and dates
- Lot #: 1020156
- Expiry3/31/2016
- Amount recalled
- 18,021 Bottles
Where it was sold
- Nationwide
Why it was recalled
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new AbbVie Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.